Filing Details

Accession Number:
0001415889-22-000324
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-04 21:28:57
Reporting Period:
2022-01-02
Accepted Time:
2022-01-04 21:28:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1604821 Natera Inc. NTRA Services-Medical Laboratories (8071) 010894487
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1711968 Leonard Steven Chapman C/O Natera, Inc.
13011 Mccallen Pass Building A Suite 100
Austin TX 78753
Ceo And President No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-01-02 3,125 $0.00 48,740 No 4 M Direct
Common Stock Acquisiton 2022-01-03 3,052 $9.29 51,792 No 4 M Direct
Common Stock Acquisiton 2022-01-03 4,072 $13.01 55,864 No 4 M Direct
Common Stock Acquisiton 2022-01-03 2,084 $20.27 57,948 No 4 M Direct
Common Stock Acquisiton 2022-01-03 18,750 $25.46 76,698 No 4 M Direct
Common Stock Disposition 2022-01-03 2,260 $86.22 74,438 No 4 S Direct
Common Stock Disposition 2022-01-03 12,890 $87.82 61,548 No 4 S Direct
Common Stock Disposition 2022-01-03 10,005 $88.44 51,543 No 4 S Direct
Common Stock Disposition 2022-01-03 1,493 $89.29 50,050 No 4 S Direct
Common Stock Disposition 2022-01-03 1,310 $90.83 48,740 No 4 S Direct
Common Stock Disposition 2022-01-03 1,209 $91.52 47,531 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Disposition 2022-01-02 3,125 $0.00 3,125 $0.00
Common Stock Stock Option (right to buy) Disposition 2022-01-03 3,052 $0.00 3,052 $9.29
Common Stock Stock Option (right to buy) Disposition 2022-01-03 4,072 $0.00 4,072 $13.01
Common Stock Stock Option (right to buy) Disposition 2022-01-03 2,084 $0.00 2,084 $20.27
Common Stock Stock Option (right to buy) Disposition 2022-01-03 18,750 $0.00 18,750 $25.46
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
12,500 No 4 M Direct
9,158 2028-03-08 No 4 M Direct
25,095 2029-01-10 No 4 M Direct
31,250 2029-04-11 No 4 M Direct
0 2030-03-26 No 4 M Direct
Footnotes
  1. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
  2. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2021, as amended on May 14, 2021.
  3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.73 to $86.69 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.11 to $88.09 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.11 to $89.10 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  6. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.12 to $89.61 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  7. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.70 to $91.10 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  8. The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs in compliance with Rule 10b5-1.
  9. The RSUs vest over four years. 25% of the RSUs vested on January 2, 2020 and the remaining shares vest in 12 equal quarterly installments thereafter.
  10. The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter.
  11. The option shares vest over four years. 25% of the option shares vested and became exercisable on January 2, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.
  12. The option shares vest over four years. 25% of the option shares vested and became exercisable on March 22, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.
  13. The option became exercisable upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achievingcertain milestones relating to the Issuer's stock price.